Identification and optimization of the chemical, series of chemicals or bio-molecule that will interact with the target using impartial, expert opinion about the best equipment, services and the latest techniques
Human Nav1.4 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6005. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , IonWorks Quattro®
Human HCN4 hyperpolarization-gated ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6006. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Nav1.5 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6007. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , PatchXpress® , IonWorks Quattro®
Human Nav1.6 sodium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6008. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , QPatch™ HT , IonWorks Quattro®
Human Nav1.3 sodium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6009. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Nav1.2 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6010. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , IonWorks Quattro®
Human ASIC1a acid-sensing ion ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6012. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human TRPM4 ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6015. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human Kv7.4 ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6016. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™ , FLIPR®
Human Kir3.1/Kir3.4 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6017. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Kv7.3/Kv7.5 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6018. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human Kv7.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6101. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , QPatch™ HT , IonWorks Quattro® , FLIPR®
Human Kir2.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6103. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human TRPV1 ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6105. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human Cav3.2 calcium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6106. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , FLIPR®
Human CFTR chloride ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6113. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ HT
Using the LiChrolut® extraction unit simplifies solid-phase extraction and makes it more rapid and reliable. The drying attachment speeds up the drying process under controlled conditions. All the individual steps associated with solid-phase extraction can be carried out using the LiChrolut® extraction unit.
Human HCN2 hyperpolarization-gated ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6115. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Nav1.8/β3 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6011. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , IonWorks Quattro®
Human NMDA (NR1/NR2A) Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6120. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human NMDA (NR1/NR2B) Receptor-expressing, stable replicating cell line (HEK293). Cat#: CT6121. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human KCa1.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6122. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , QPatch™ HT , FLIPR®
Human kCa3.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6123. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™
Human Kir2.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6127. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quatto® , QPatch™HT
Human Kv1.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6130. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
